European Archives - Page 964 of 1486 - European Medical Journal

EMJ Podcast: Putting the 'Ease' in Diabetes

Jonathan sits down with Mark Barone, Vice President, International Diabetes Foundation, for a discussion about his personal experience with diabetes, how the medical professional can encourage healthier lifestyle choices, and how we can tackle health inequities in diabetes and beyond.

Do Microglia Drive Depressive Symptoms in Neurological Disorders?

MICROGLIA have been shown in previous research to be activated in several neurological diseases, including Parkinson’s disease and Alzheimer’s disease…

Brain Fog in COVID-19 Linked to Inflammatory Markers in the Cerebrospinal Fluid

BRAIN fog is one of many neurological symptoms associated with coronavirus disease (COVID-19), but it is not understood what causes this symptom…

EMJ Rheumatology 8 [Supplement 1] 2021

This review provides a summary of presentations from the virtual American College of Rheumatology (ACR) Convergence 2020 meeting…

Diagnosis, Treatment Management, and the Genetic Basis of Psoriasis, Psoriatic Arthritis, and Spondyloarthritis

Psoriatic arthritis (PsA) is an inflammatory condition of the joints and the areas where tendons and ligaments connect with bone…

Exercise During Pregnancy May Reduce Risk of Gestational Diabetes Mellitus

INCREASED exercise during the first trimester of pregnancy may lower risk of developing gestational diabetes mellitus (GDM), a new study at the University of Tennessee, Knoxville, Tennessee, USA found. GDM is diabetes that is diagnosed for the first time during pregnancy.

Metabolic Surgery for the Long-term Treatment of Diabetes

TEN-YEAR clinical trial data reported that metabolic surgery is the best treatment option for long-term diabetes remission. The trial, undertaken by researchers from King’s College London, London, UK, and the Gemelli University Hospital, Rome, Italy, represented the longest follow-up study to date and showed that surgery is more effective than conventional treatment in the management of Type 2 diabetes mellitus (T2DM).

Final Results from the ClarIDHy Phase III Study of Ivosidenib Versus Placebo in Patients with Previously Treated Cholangiocarcinoma and an Isocitrate Dehydrogenase 1 (IDH1) Mutation

Cholangiocarcinoma (CCA) is a rare cancer for which there are limited effective therapies.1,2 Mutations in the isocitrate dehydrogenase 1 gene (IDH1)…

EMJ Oncology 9 [Supplement 2] 2021 Feature Image

EMJ Oncology 9 [Supplement 2] 2021

ONCOGENESIS in cholangiocarcinoma, a rare cancer, can be driven by the oncometabolite D-2-hydroxyglutarate, produced as a result…

Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights

Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…